tiprankstipranks
Trending News
More News >
UroGen Pharma price target raised to $47 from $23 at Scotiabank
PremiumThe FlyUroGen Pharma price target raised to $47 from $23 at Scotiabank
15d ago
FDA Approves Urogen Pharma’s ZUSDURI for Bladder Cancer
Premium
Company Announcements
FDA Approves Urogen Pharma’s ZUSDURI for Bladder Cancer
15d ago
UroGen Pharma price target raised to $30 from $15 at Guggenheim
Premium
The Fly
UroGen Pharma price target raised to $30 from $15 at Guggenheim
15d ago
UroGen Pharma trading halted, news pending
PremiumThe FlyUroGen Pharma trading halted, news pending
16d ago
UroGen Pharma put volume heavy and directionally bearish
Premium
The Fly
UroGen Pharma put volume heavy and directionally bearish
17d ago
UroGen Faces Legal Battle Over Misleading FDA Claims
Premium
Class Action
UroGen Faces Legal Battle Over Misleading FDA Claims
24d ago
UroGen Pharma down over 50% after resuming trading
PremiumThe FlyUroGen Pharma down over 50% after resuming trading
1M ago
UroGen says FDA panel votes against benefit/risk of UGN-102
Premium
The Fly
UroGen says FDA panel votes against benefit/risk of UGN-102
1M ago
UroGen Pharma announces outcome of ODAC meeting for UGN-102
Premium
The Fly
UroGen Pharma announces outcome of ODAC meeting for UGN-102
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100